Product Description
Tenfoplus 25 mg Tenofovir Alafenamide Tablets are formulated to effectively manage HIV infection and chronic hepatitis B virus (HBV) infection. Each tablet contains 25 mg of Tenofovir Alafenamide, delivered in an easy-to-consume physical tablet form. This medication is classified under general medicines, making it widely accessible for treatment purposes. The tablets are packaged in boxes containing 30 units, ensuring sufficient supply for therapeutic requirements. Designed to meet high-quality standards, this product is suitable for distributors, retailers, suppliers, traders, and wholesalers seeking effective solutions for individuals suffering from viral infections. Follow prescribed dosage guidelines for optimal results.
FAQs of Tenfoplus 25 mg Tenofovir Alafenamide Tablets:
Q: What is the intended use of Tenfoplus 25 mg Tenofovir Alafenamide Tablets?
A: These tablets are primarily used for managing HIV infections and chronic hepatitis B virus (HBV) infections.
Q: How is the dosage of Tenfoplus structured?
A: Each tablet contains 25 mg of Tenofovir Alafenamide, as recommended for treatment by healthcare providers.
Q: In what form is this medication available?
A: These tablets are provided in physical form and packaged in boxes containing 30 tablets.
Q: What type of drug is Tenfoplus classified under?
A: Tenfoplus 25 mg is classified as general medicine for therapeutic applications.
Q: Who is eligible to supply this product?
A: Distributors, retailers, suppliers, traders, and wholesalers can provide Tenfoplus 25 mg to healthcare entities.